FAAH
Fatty acid amide hydrolase (FAAH), belonging to an amidase-signature (AS) protein family, is a membrane-bound protein predominantly in microsomal and mitochondrial fractions that catalyzes the hydrolysis of several bioactive lipids, including anandamide, 2-arachidonoylglycerol (2-AG) and oleamide. The mammalian FAAHs are 63 kDa (579 amino acids in length) proteins characterized by containing several domains defined by homology and function, including, a highly conserved seine-and-glycine-rich AS domain, a predicted transmembrane domain and a proline rich domain. Results of mutation studies suggest, unlike other members of AS protein family, the catalytic activity of FAAH is not associated with the Ser-His-Asp triad but possibly with Ser217 and Lys142.
-
A3571 LY2183240Summary: Blocker of anandamide uptake,highly potent
-
A4361 JNJ-1661010Summary: FAAH inhibitor,potent and selective
-
A4372 URB597Summary: FAAH inhibitor,potent and selective
-
A4374 PF-38451 CitationTarget: FAAHSummary: FAAH ihibitor,highly potent and selective
-
C4122 JNJ-42165279Summary: FAAH inhibitor
-
C4251 Oleoyl Ethyl AmideSummary: FAAH inhibitor with potential analgesic and anxiolytic activity
-
C4279 4-(n-nonyl) Benzeneboronic AcidSummary: FAAH and MAGL inhibitor
-
C4756 PF-622Summary: potent, time-dependent, irreversible FAAH inhibitor
-
C4983 JP83Summary: irreversible fatty acyl amide hydrolase (FAAH) inhibitor
-
C5178 Methyl α-Linolenyl FluorophosphonateSummary: inhibitor of phospholipases, FAAH